BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19875755)

  • 1. Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study.
    Lahat G; Tuvin D; Wei C; Wang WL; Pollock RE; Anaya DA; Bekele BN; Corely L; Lazar AJ; Pisters PW; Lev D
    Ann Oncol; 2010 May; 21(5):1112-20. PubMed ID: 19875755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives for staging and prognosis in soft tissue sarcoma.
    Lahat G; Tuvin D; Wei C; Anaya DA; Bekele BN; Lazar AJ; Pisters PW; Lev D; Pollock RE
    Ann Surg Oncol; 2008 Oct; 15(10):2739-48. PubMed ID: 18521685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304.
    Tanaka K; Hasegawa T; Nojima T; Oda Y; Mizusawa J; Fukuda H; Iwamoto Y
    World J Surg Oncol; 2016 Apr; 14():110. PubMed ID: 27091124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
    Engellau J
    Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in soft tissue sarcoma.
    Maretty-Nielsen K
    Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
    Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort.
    Garcia C; Kubat JS; Fulton RS; Anthony AT; Combs M; Powell CB; Littell RD
    Int J Gynecol Cancer; 2015 May; 25(4):622-8. PubMed ID: 25675041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
    Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
    Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
    Xu YP; Zhao XQ; Sommer K; Moubayed P
    J Zhejiang Univ Sci; 2003; 4(4):491-501. PubMed ID: 12861629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
    Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
    Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of WT1 expression in soft tissue sarcoma.
    Kim A; Park EY; Kim K; Lee JH; Shin DH; Kim JY; Park DY; Lee CH; Sol MY; Choi KU; Kim JI; Lee IS
    World J Surg Oncol; 2014 Jul; 12():214. PubMed ID: 25026998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
    Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
    Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.